This presentation was recorded for the Virtual #CochraneSantiago Colloquium, 2019 (November). The title of the presentation is ‘PRISMA 2020 statement: updated guidelines for reporting systematic reviews and meta-analyses’. Presented by Matthew J Page.
"PRISMA is an evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. PRISMA focuses on the reporting of reviews evaluating randomized trials, but can also be used as a basis for reporting systematic reviews of other types of research, particularly evaluations of interventions."
Extensions of the PRISMA Statement have been developed to facilitate the reporting of different types or aspects of systematic reviews. Those include:
- PRISMA for Abstracts
- PRISMA Equity
- PRISMA Harms (for reviews including Harm outcomes)
- PRISMA Individual Patient Data
- PRISMA for Network Meta-Analyses
- PRISMA for Protocols
- PRISMA for Diagnostic Test Accuracy
- PRISMA for Scoping Reviews
- PRISMA for Acupuncture
- Extensions in development